Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|
Jerusalem - GBC
JER - GBC
|
2045 | P | 14 | 26.0 | 1 | 1 | 0 | 1.000 | 0.69 | .060 | -0.69 |
Jerusalem - GBC
JER - GBC
|
2044 | P | 16 | 74.0 | 3 | 5 | 0 | 1.000 | 0.97 | 1.059 | 0.88 |
Total | P | 30 | 100.0 | 4 | 6 | 0 | 0.20 |
Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|
Johannesburg - ABA
JOH - ABA
|
2045 | P | 28 | 89.2 | 3 | 7 | 0 | 1.000 | 1.00 | 1.196 | 0.86 |
Johannesburg - ABA
JOH - ABA
|
2044 | P | 1 | 7.2 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Winnipeg - RHML (AAA)
WPG - RHML (AAA)
|
2044 | P | 13 | 88.1 | 6 | 9 | 1 | .938 | 1.53 | 1.051 | 1.85 |
Winnipeg - RHML (AAA)
WPG - RHML (AAA)
|
2043 | P | 3 | 8.1 | 1 | 1 | 0 | 1.000 | 2.16 | 1.050 | -0.12 |
Saskatchewan - WCL (AA)
SAS - WCL (AA)
|
2043 | P | 14 | 41.0 | 2 | 3 | 0 | 1.000 | 1.10 | 1.033 | 0.14 |
Winnipeg - RHML (AAA)
WPG - RHML (AAA)
|
2042 | P | 9 | 28.1 | 0 | 6 | 0 | 1.000 | 1.91 | 1.066 | 0.34 |
Nike - CCAS (COL)
NIK - CCAS (COL)
|
2041 | P | 15 | 25.2 | 1 | 3 | 1 | .800 | 1.40 | .856 | -0.58 |
Nike - CCAS (COL)
NIK - CCAS (COL)
|
2040 | P | 10 | 52.0 | 3 | 5 | 0 | 1.000 | 1.38 | .736 | -1.13 |
Nike - CCAS (COL)
NIK - CCAS (COL)
|
2039 | P | 8 | 39.0 | 0 | 4 | 0 | 1.000 | 0.92 | .831 | -0.72 |
Nike - CCAS (COL)
NIK - CCAS (COL)
|
2038 | P | 23 | 25.0 | 1 | 2 | 0 | 1.000 | 1.08 | 2.042 | 0.09 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2037 | P | 9 | 13.0 | 0 | 1 | 1 | .500 | 0.69 | .542 | -1.03 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2036 | P | 11 | 9.0 | 0 | 1 | 1 | .500 | 1.00 | 1.043 | -0.13 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2035 | P | 11 | 16.2 | 1 | 4 | 0 | 1.000 | 2.70 | 1.301 | 0.31 |
Merrill Lynch - IFC
ML - IFC
|
2034 | P | 10 | 47.2 | 1 | 8 | 1 | .900 | 1.70 | 1.175 | 0.69 |
Total | P | 165 | 491.1 | 19 | 54 | 5 | 0.58 |